FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3017333120> ?p ?o ?g. }

• W3017333120 abstract "Background: Along with lack of studies that systematically address the transfusion requirements and triggers in acute leukemia, no study to date has addressed the blood product use with respect to ongoing chemotherapy (CT) in pediatric acute lymphoblastic leukemia (ALL) patients. Objectives: This study was therefore designed to evaluate total erythrocyte, random platelet and apheresis platelet suspension requirement in pediatric ALL patients in relation to ongoing CT protocols. Methods: A total of 146 pediatric patients with ALL were included in this retrospective study. Data on patient demographics, CT protocol, amount and efficacy of blood product use (erythrocytes, apheresis platelet and random platelet), and survival during CT were retrieved from hospital records. Results: The average amount of erythrocytes, apheresis platelets and random platelets received by 146 ALL patients from the date of diagnosis were 14 (3 - 78) bags, 9 (1 - 97 bags and 11 (1 - 83) bags, respectively. Protocol 1b augmented was associated with the highest amount of erythrocyte use (P < 0.001), while no significant difference was noted in apheresis platelet and random platelet use with respect to CT regimens. Erythrocyte transfusion was associated with a more marked increase in hemoglobin (Hb), erythrocyte (RBC), leukocyte (WBC), lymphocyte and neutrophil counts as compared with apheresis platelet and random platelet infusions, while protocol 2 was associated with higher Hb (P = 0.017) levels after erythrocyte transfusion. Conclusions: Our findings indicate a great amount of blood product transfusion to be required in children with ALL under CT and emphasize the likelihood of transfusion need and efficacy of transfusion to alter with respect to ongoing CT regimen. The need in patients using augmented BFM protocol 1 b was highest, and albeit the need of blood and blood product transfusions vary within patients, the anticipated median need for blood products at diagnosis and at various blocks of treatment may be helpful for the blood banks, doctors of the respective pediatric hematology-oncology centers to plan as patients are treated." @default.
• W3017333120 created "2020-04-24" @default.
• W3017333120 creator A5027765678 @default.
• W3017333120 creator A5052872059 @default.
• W3017333120 date "2020-04-14" @default.
• W3017333120 modified "2023-09-27" @default.
• W3017333120 title "Blood Product Requirement in Childhood Acute Lymphoblastic Leukemia in Relation to Chemotherapy Regimens" @default.
• W3017333120 cites W1558704041 @default.
• W3017333120 cites W1977898131 @default.
• W3017333120 cites W2006072637 @default.
• W3017333120 cites W2019799425 @default.
• W3017333120 cites W2033499033 @default.
• W3017333120 cites W2084834413 @default.
• W3017333120 cites W2093255106 @default.
• W3017333120 cites W2136098489 @default.
• W3017333120 cites W2151783718 @default.
• W3017333120 cites W2163034869 @default.
• W3017333120 cites W2235523093 @default.
• W3017333120 cites W2434024560 @default.
• W3017333120 cites W2557595413 @default.
• W3017333120 cites W2773095864 @default.
• W3017333120 cites W2901885843 @default.
• W3017333120 cites W2913396255 @default.
• W3017333120 cites W2947408567 @default.
• W3017333120 doi "https://doi.org/10.5812/ijp.100823" @default.
• W3017333120 hasPublicationYear "2020" @default.
• W3017333120 type Work @default.
• W3017333120 sameAs 3017333120 @default.
• W3017333120 citedByCount "0" @default.
• W3017333120 crossrefType "journal-article" @default.
• W3017333120 hasAuthorship W3017333120A5027765678 @default.
• W3017333120 hasAuthorship W3017333120A5052872059 @default.
• W3017333120 hasBestOaLocation W30173331201 @default.
• W3017333120 hasConcept C126322002 @default.
• W3017333120 hasConcept C141071460 @default.
• W3017333120 hasConcept C167135981 @default.
• W3017333120 hasConcept C2776689292 @default.
• W3017333120 hasConcept C2776694085 @default.
• W3017333120 hasConcept C2776738589 @default.
• W3017333120 hasConcept C2776863199 @default.
• W3017333120 hasConcept C2777396833 @default.
• W3017333120 hasConcept C2778461978 @default.
• W3017333120 hasConcept C71924100 @default.
• W3017333120 hasConcept C89560881 @default.
• W3017333120 hasConceptScore W3017333120C126322002 @default.
• W3017333120 hasConceptScore W3017333120C141071460 @default.
• W3017333120 hasConceptScore W3017333120C167135981 @default.
• W3017333120 hasConceptScore W3017333120C2776689292 @default.
• W3017333120 hasConceptScore W3017333120C2776694085 @default.
• W3017333120 hasConceptScore W3017333120C2776738589 @default.
• W3017333120 hasConceptScore W3017333120C2776863199 @default.
• W3017333120 hasConceptScore W3017333120C2777396833 @default.
• W3017333120 hasConceptScore W3017333120C2778461978 @default.
• W3017333120 hasConceptScore W3017333120C71924100 @default.
• W3017333120 hasConceptScore W3017333120C89560881 @default.
• W3017333120 hasLocation W30173331201 @default.
• W3017333120 hasOpenAccess W3017333120 @default.
• W3017333120 hasPrimaryLocation W30173331201 @default.
• W3017333120 hasRelatedWork W12777725 @default.
• W3017333120 hasRelatedWork W14268349 @default.
• W3017333120 hasRelatedWork W16967440 @default.
• W3017333120 hasRelatedWork W19246658 @default.
• W3017333120 hasRelatedWork W20902414 @default.
• W3017333120 hasRelatedWork W3953581 @default.
• W3017333120 hasRelatedWork W42601 @default.
• W3017333120 hasRelatedWork W6605387 @default.
• W3017333120 hasRelatedWork W8084073 @default.
• W3017333120 hasRelatedWork W8887711 @default.
• W3017333120 isParatext "false" @default.
• W3017333120 isRetracted "false" @default.
• W3017333120 magId "3017333120" @default.
• W3017333120 workType "article" @default.